Carl Ola Landgren (Ola Landgren, C Ola Landgren)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 85

Top Venues

Blood cancer journal

Nature medicine

Leukemia & lymphoma

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin T Diamond, Bachisio Ziccheddu, Kylee H Maclachlan, Justin Taylor, Eileen Mary Boyle, Juan Esteban Arango Ossa, Thomas Jacob Jahn, Maurizio Affer, Tulasigeri M Totiger, David G Coffey, Namrata S Chandhok, Justin M Watts, Luisa Cimmino, Sydney X Lu, Niccolo' Bolli, Kelly L Bolton, Heather J Landau, Jae H Park, Karuna Ganesh, Andrew W McPherson, Mikkael A Sekeres, Alexander M Lesokhin, David J Chung, Yanming Zhang, Caleb Ho, Mikhail Roshal, Jeffrey W Tyner, Stephen D Nimer, Elli Papaemmanuil, Saad Z Usmani, Gareth J Morgan, Carl Ola Landgren, Francesco Maura
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures. Blood (2023)
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin L Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi A Shah, Kylee H Maclachlan, Dhwani Patel, Oscar B Lahoud, Heather J Landau, David J Chung, Gunjan L Shah, Michael Scordo, Sergio A Giralt, Alexander Lesokhin, Saad Usmani, Carl Ola Landgren, Neha Korde
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma. Research square (2023)
Saemundur Rognvaldsson, Thorvardur Jon Love, Sigrún Þorsteinsdóttir, Elín Ruth Reed, Jón Þórir Óskarsson, Íris Pétursdóttir, Guðrún Ásta Sigurðardóttir, Brynjar Viðarsson, Páll Torfi Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Ásdís Rósa Þórðardóttir, Elías Eyþórsson, Ásbjörn Jónsson, Andri S Björnsson, Gunnar Þór Gunnarsson, Runólfur Pálsson, Ólafur Skúli Indriðason, Gauti Kjartan Gíslason, Andri Ólafsson, Guðlaug Katrín Hákonardóttir, Manje Brinkhuis, Sara Lovísa Halldórsdóttir, Tinna Laufey Ásgeirsdóttir, Hlíf Steingrímsdóttir, Ragnar Danielsen, Inga Dröfn Wessman, Petros Kampanis, Malin Hultcrantz, Brian G M Durie, Stephen Harding, Carl Ola Landgren, Sigurður Yngvi Kristinsson
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood cancer journal 13 (1) (2023)
Francesco Maura, David G Coffey, Caleb K Stein, Esteban Braggio, Bachisio Ziccheddu, Meaghen E Sharik, Megan Du, Yuliza Tofaya Alvarado, Chang-Xin Shi, Yuan Xiao Zhu, Erin W Meermeier, Gareth J Morgan, Carl Ola Landgren, Peter Leif Bergsagel, Marta Chesi
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity. bioRxiv : the preprint server for biology (2023)
Holly Lee, Sungwoo Ahn, Ranjan Maity, Noemie Leblay, Bachisio Ziccheddu, Marietta Truger, Monika Chojnacka, Anthony Cirrincione, Michael A Durante, Remi Tilmont, Elie Barakat, Mansour Poorebrahim, Sarthak Sinha, John McIntyre, Angela M Y Chan, Holly Wilson, Shari Kyman, Amrita Krishnan, Carl Ola Landgren, Wencke Walter, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach, Hermann Einsele, Klaus Martin Kortüm, Stefan Knop, Jean Baptiste Alberge, Andreas Rosenwald, Jonathan J Keats, Leo Rasche, Francesco Maura, Paola Neri, Nizar J Bahlis
Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nature medicine (2023)
Janine Marie Joseph, Jens Hillengass, Li Tang, Alexander M Lesokhin, Carl Ola Landgren, Saad Z Usmani, Kirsten B Moysich, Susan McCann, Urvi A Shah
Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. Blood advances (2023)
Urvi A Shah, Karissa Whiting, Sean Devlin, Rachel Ershler, Bindu Kanapuru, David J Lee, Sabrin Tahri, Thomas Gwise, Even H Rustad, Sham Mailankody, Alexander M Lesokhin, Dickran Kazandjian, Francesco Maura, Daniel Auclair, Brenda M Birmann, Saad Z Usmani, Nicole Gormley, Catherine R Marinac, Carl Ola Landgren
Extreme body mass index and survival in newly diagnosed multiple myeloma patients. Blood cancer journal 13 (1) (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine 29 (2) (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine 29 (2) (2023)
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin L Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi A Shah, Kylee H Maclachlan, Dhwani Patel, Oscar B Lahoud, Heather J Landau, David J Chung, Gunjan L Shah, Michael Scordo, Sergio A Giralt, Alexander Lesokhin, Saad Z Usmani, Carl Ola Landgren, Neha Korde
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Urvi A Shah, Karissa Whiting, Sean Devlin, Rachel Ershler, Bindu Kanapuru, David J Lee, Sabrin Tahri, Thomas Gwise, Even H Rustad, Sham Mailankody, Alexander M Lesokhin, Dickran Kazandjian, Francesco Maura, Daniel Auclair, Brenda M Birmann, Saad Z Usmani, Nicole Gormley, Catherine R Marinac, Carl Ola Landgren
Extreme body mass index and survival in newly diagnosed multiple myeloma patients. Blood cancer journal 13 (1) (2023)
Saemundur Rognvaldsson, Thorvardur Jon Love, Sigrún Þorsteinsdóttir, Elín Ruth Reed, Jón Þórir Óskarsson, Íris Pétursdóttir, Guðrún Ásta Sigurðardóttir, Brynjar Viðarsson, Páll Torfi Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Ásdís Rósa Þórðardóttir, Elías Eyþórsson, Ásbjörn Jónsson, Andri S Björnsson, Gunnar Þór Gunnarsson, Runólfur Pálsson, Ólafur Skúli Indriðason, Gauti Kjartan Gíslason, Andri Ólafsson, Guðlaug Katrín Hákonardóttir, Manje Brinkhuis, Sara Lovísa Halldórsdóttir, Tinna Laufey Ásgeirsdóttir, Hlíf Steingrímsdóttir, Ragnar Danielsen, Inga Dröfn Wessman, Petros Kampanis, Malin Hultcrantz, Brian G M Durie, Stephen Harding, Carl Ola Landgren, Sigurður Yngvi Kristinsson
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood cancer journal 13 (1) (2023)
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, Even Rustad, Kylee Maclachlan, Marios Papadimitriou, Eileen Mary Boyle, Patrick Blaney, Saad Usmani, Gareth Morgan, Carl Ola Landgren, Francesco Maura
Impact of rare structural variant events in newly diagnosed multiple myeloma. bioRxiv : the preprint server for biology (2023)
Carl Ola Landgren, Omar Nadeem
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast. Advances in therapy (2023)
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin L Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi A Shah, Kylee H Maclachlan, Dhwani Patel, Oscar B Lahoud, Heather J Landau, David J Chung, Gunjan L Shah, Michael Scordo, Sergio A Giralt, Alexander Lesokhin, Saad Usmani, Carl Ola Landgren, Neha Korde
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma. Research square (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine 29 (2) (2023)
Urvi A Shah, Karissa Whiting, Sean Devlin, Rachel Ershler, Bindu Kanapuru, David J Lee, Sabrin Tahri, Thomas Gwise, Even H Rustad, Sham Mailankody, Alexander M Lesokhin, Dickran Kazandjian, Francesco Maura, Daniel Auclair, Brenda M Birmann, Saad Z Usmani, Nicole Gormley, Catherine R Marinac, Carl Ola Landgren
Extreme body mass index and survival in newly diagnosed multiple myeloma patients. Blood cancer journal 13 (1) (2023)
Saad Z Usmani, Hang Quach, Maria-Victoria Mateos-Manteca, Carl Ola Landgren, Xavier Leleu, David S Siegel, Katja C Weisel, Xiaomei Shu, Chuang Li, Meletios A Dimopoulos
Final Analysis of Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in the CANDOR Study. Blood advances (2023)
David G Coffey, Francesco Maura, Edgar G Kozlova, J Javier Diaz-Mejia, Ping Luo, Yong Zhang, Yuexin Xu, Edus H Warren, Travis Dawson, Brian Lee, Hui Xie, Eric L Smith, Amanda Ciardiello, Hearn Jay Cho, Adeeb Rahman, Seunghee Kim-Schulze, Benjamin T Diamond, Alexander Lesokhin, Dickran Kazandjian, Trevor J Pugh, Damian J Green, Sacha Gnjatic, Carl Ola Landgren
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma. Nature communications 14 (1) (2023)
Benjamin T Diamond, Bachisio Ziccheddu, Kylee H Maclachlan, Justin Taylor, Eileen Mary Boyle, Juan Esteban Arango Ossa, Thomas Jacob Jahn, Maurizio Affer, Tulasigeri M Totiger, David G Coffey, Namrata S Chandhok, Justin M Watts, Luisa Cimmino, Sydney X Lu, Niccolo' Bolli, Kelly L Bolton, Heather J Landau, Jae H Park, Karuna Ganesh, Andrew W McPherson, Mikkael A Sekeres, Alexander M Lesokhin, David J Chung, Yanming Zhang, Caleb Ho, Mikhail Roshal, Jeffrey W Tyner, Stephen D Nimer, Elli Papaemmanuil, Saad Z Usmani, Gareth J Morgan, Carl Ola Landgren, Francesco Maura
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures. Blood (2023)
Francesco Maura, Bachisio Ziccheddu, Jenny Zhaoying Xiang, Bhavneet Bhinder, Joel Rosiene, Federico Abascal, Kylee H Maclachlan, Kenneth Wha Eng, Manik Uppal, Feng He, Wei Zhang, Qi Gao, Venkata D Yellapantula, Vicenta Trujillo-Alonso, Sunita I Park, Matthew J Oberley, Elizabeth Ruckdeschel, Megan S Lim, Gerald B Wertheim, Matthew J Barth, Terzah M Horton, Andriy Derkach, Alexandra Elizabeth Kovach, Christopher J Forlenza, Yanming Zhang, Carl Ola Landgren, Craig H Moskowitz, Ethel Cesarman, Marcin Imielinski, Olivier Elemento, Mikhail Roshal, Lisa Giulino-Roth
Molecular evolution of classic Hodgkin lymphoma revealed through whole genome sequencing of Hodgkin and Reed Sternberg cells. Blood cancer discovery (2023)
Francesco Maura, Eileen M Boyle, David Coffey, Kylee H Maclachlan, Dylan Gagler, Benjamin T Diamond, Hussein Ghamlouch, Patrick Blaney, Bachisio Ziccheddu, Anthony Cirrincione, Monika Chojnacka, Yubao Wang, Ariel Siegel, James E Hoffman, Dickran Kazandjian, Hani Hassoun, Emily Guzman, Sham Mailankody, Urvi A Shah, Carlyn Rose Tan, Malin L Hultcrantz, Michael Scordo, Gunjan L Shah, Heather Landau, David J Chung, Sergio Giralt, Yanming Zhang, Arnaldo Arbini, Qi Gao, Mikhail Roshal, Ahmet Dogan, Alexander M Lesokhin, Faith E Davies, Saad Z Usmani, Neha Korde, Gareth J Morgan, Carl Ola Landgren
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens. Nature cancer (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine 29 (2) (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine (2023)
Urvi A Shah, Karissa Whiting, Sean Devlin, Rachel Ershler, Bindu Kanapuru, David J Lee, Sabrin Tahri, Thomas Gwise, Even H Rustad, Sham Mailankody, Alexander M Lesokhin, Dickran Kazandjian, Francesco Maura, Daniel Auclair, Brenda M Birmann, Saad Z Usmani, Nicole Gormley, Catherine R Marinac, Carl Ola Landgren
Extreme body mass index and survival in newly diagnosed multiple myeloma patients. Blood cancer journal 13 (1) (2023)
Carl Ola Landgren, Dickran Kazandjian
MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Myeloma. Blood cancer discovery 4 (5) (2023)
Eileen Mary Boyle, Patrick Blaney, James H Stoeckle, Yubao Wang, Hussein Ghamlouch, Dylan Gagler, Marc J Braunstein, Louis Williams, Avital Tenenbaum, Ariel M Siegel, Xiaoyi Chen, Gaurav Varma, Jason Avigan, Alexander Li, Monica Jinsi, David Kaminetzky, Arnaldo Arbini, Lydia Montes, Jill Corre, Even Holth Rustad, Carl Ola Landgren, Francesco Maura, Brian A Walker, Michael A Bauer, Benedetto Bruno, Aristotelis Tsirigos, Faith E Davies, Gareth J Morgan
Multiomic mapping of acquired chromosome 1 copy number and structural variants to identify therapeutic vulnerabilities in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Monika Chojnacka, Benjamin T Diamond, Bachisio Ziccheddu, Even Holth Rustad, Kylee H Maclachlan, Marios Papadimitriou, Eileen Mary Boyle, Patrick Blaney, Saad Z Usmani, Gareth J Morgan, Carl Ola Landgren, Francesco Maura
Impact of rare structural variant events in newly diagnosed multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hultcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hulcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine 29 (2) (2023)
Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Oscar Berlanga, Malin Hultcrantz, Brian G M Durie, Thorvardur J Löve, Stephen Harding, Carl Ola Landgren, Sigurður Y Kristinsson
Prevalence of smoldering multiple myeloma based on nationwide screening. Nature medicine 29 (2) (2023)
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin L Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi A Shah, Kylee H Maclachlan, Dhwani Patel, Oscar B Lahoud, Heather J Landau, David J Chung, Gunjan L Shah, Michael Scordo, Sergio A Giralt, Alexander Lesokhin, Saad Usmani, Carl Ola Landgren, Neha Korde
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma. Research square (2023)
Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, Meghan Salcedo, Kelly Barnett, Julia Caple, Jenna Blaslov, Linh Tran, Amanda Ciardiello, Miranda Burge, Tala Shekarkhand, Peter A Adintori, Justin R Cross, Matthew J Pianko, Kinga K Hosszu, Devin McAvoy, Sham Mailankody, Neha Korde, Malin L Hultcrantz, Hani Hassoun, Carlyn Rose Tan, Sydney X Lu, Dhwani Patel, Benjamin T Diamond, Gunjan L Shah, Michael Scordo, Oscar B Lahoud, David J Chung, Heather J Landau, Saad Z Usmani, Sergio A Giralt, Ying Taur, Carl Ola Landgren, Gladys Block, Torin J Block, Jonathan U Peled, Marcel R M van den Brink, Alexander M Lesokhin
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Maria A Malik, Nathan W Sweeney, Mohammad Jafri, Andriy Derkach, Cynthia Chmielewski, Peter A Adintori, Sham Mailankody, Neha Korde, Carlyn R Tan, Hani Hassoun, Malin L Hultcrantz, Jens Hillengass, Susan E McCann, Neil Iyengar, Saad Usmani, Sergio A Giralt, Carl Ola Landgren, Marcel R M van den Brink, Jennifer M Ahlstrom, Alexander M Lesokhin, Anita D Souza, Susan Chimonas, Urvi A Shah
Nutrition perceptions, needs and practices among patients with plasma cell disorders. Blood cancer journal 12 (4) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Sakshi Jasra, Orsi Giricz, Rachel Zeig-Owens, Kith Pradhan, David G Goldfarb, Angelica Barreto-Galvez, Alexander J Silver, Jiahao Chen, Srabani Sahu, Shanisha Gordon-Mitchell, Gaurav S Choudhary, Srinivas Aluri, Tushar D Bhagat, Aditi Shastri, Cosmin A Bejan, Shannon S Stockton, Travis P Spaulding, Victor Thiruthuvanathan, Hiroki Goto, Jeannine Gerhardt, Syed Hissam Haider, Arul Veerappan, Matthias Bartenstein, George Nwankwo, Carl Ola Landgren, Michael D Weiden, Jacqueline Lekostaj, Ryan Bender, Frederick Fletcher, Lee Greenberger, Benjamin L Ebert, Ulrich Steidl, Britta Will, Anna Nolan, Advaitha Madireddy, Michael R Savona, David J Prezant, Amit K Verma
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster. Nature medicine 28 (3) (2022)
Karthik D Nath, Tala Shekarkhand, Meghan Salcedo, Andriy Derkach, Siobhan Rueda, Aisara Chansakul, Malin Hulcrantz, Neha Korde, Urvi A Shah, Carlyn Rose Tan, David J Chung, Oscar B Lahoud, Hani Hassoun, Alexander M Lesokhin, Heather J Landau, Gunjan Shah, Michael Scordo, Sergio A Giralt, Saad Z Usmani, Mikhail Roshal, Carl Ola Landgren, Sham Mailankody
A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Leukemia & lymphoma (2022)
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, Rawan Faramand, Anthony J Griswold, Kayla M Reid, Meghan Menges, Yonghong Zhang, Ling Cen, Xuefeng Wang, Mohammad Hussaini, Carl Ola Landgren, Marco L Davila, Jonathan H Schatz, Frederick L Locke, Francesco Maura
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma. Blood 140 (5) (2022)
Sham Mailankody, Meghan Salcedo, Elizabet Tavitian, Miranda Burge, Neha Korde, Hani Hassoun, Alexander M Lesokhin, Oscar B Lahoud, Eric Smith, Malin Hultcrantz, Carlyn Rose Tan, Urvi A Shah, Sean Devlin, Carl Ola Landgren
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study. Leukemia & lymphoma 63 (11) (2022)
Vicky C Chang, Ali A Khan, Wen-Yi Huang, Hormuzd A Katki, Mark P Purdue, Carl Ola Landgren, Jonathan N Hofmann
Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Blood cancer journal 12 (4) (2022)
Carl Ola Landgren, Katja Weisel, Laura Rosinol, Cyrille Touzeau, Mehmet Turgut, Roman Hájek, Peter Mollee, Jin Seok Kim, Natalie Shu, Xuguang Hu, Chuang Li, Saad Z Usmani
Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study. British journal of haematology 198 (6) (2022)
Carl Ola Landgren, Dickran Kazandjian
Modern Myeloma Therapy + Sustained Minimal Residual Disease-Negative = (Functional) Cure! Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Ari P Bernstein, Justin Loloi, Rohit Reddy, Christian Ramsoomair, Katherine Campbell, Francesco Maura, Carl Ola Landgren, Daniel Nassau, Emad Ibrahim, Ranjith Ramasamy
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning. Nature reviews. Urology 19 (9) (2022)
Kylee H Maclachlan, Tina Bagratuni, Efstathios Kastritis, Bachisio Ziccheddu, Sydney X Lu, Venkata Yellapantula, Christopher A Famulare, Kimon V Argyropoulos, Andriy Derkach, Elli Papaemmanuil, Ahmet Dogan, Alexander M Lesokhin, Saad Z Usmani, Carl Ola Landgren, Maria Lia Palomba, Francesco Maura, Meletios A Dimopoulos
Waldenström Macroglobulinemia Whole Genome Reveals Prolonged Germinal Center Activity and Late Copy Number Aberrations. Blood advances (2022)
Carl Ola Landgren, Dickran Kazandjian
Diagnosed with myeloma before age 40. Blood 138 (25) (2022)
Thorir Einarsson Long, Olafur Skuli Indridason, Runolfur Palsson, Saemundur Rognvaldsson, Thorvardur Jon Love, Sigrún Þorsteinsdóttir, Ingigerdur Solveig Sverrisdottir, Brynjar Vidarsson, Pall Torfi Onundarson, Bjarni Agnar Agnarsson, Margret Sigurdardottir, Ingunn Thorsteinsdottir, Isleifur Olafsson, Asdis Rosa Thordardottir, Elias Eythorsson, Asbjorn Jonsson, Gauti Kjartan Gíslason, Andri Olafsson, Hlif Steingrimsdottir, Malin L Hultcrantz, Brian G M Durie, Stephen Harding, Carl Ola Landgren, Sigurður Yngvi Kristinsson
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study. Blood cancer journal 12 (9) (2022)
Cody Ashby, Eileen Mary Boyle, Michael A Bauer, Aneta Mikulasova, Christopher Paul Wardell, Louis Williams, Ariel Siegel, Patrick Blaney, Marc Braunstein, David Kaminetsky, Jonathan J Keats, Francesco Maura, Carl Ola Landgren, Brian A Walker, Faith E Davies, Gareth J Morgan
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma. Blood cancer journal 12 (5) (2022)
Rachel Zeig-Owens, David G Goldfarb, Benjamin J Luft, Xiaohua Yang, Kazunori Murata, Lakshmi Ramanathan, Katie Thoren, Sital Doddi, Urvi A Shah, Alexandra K Mueller, Charles B Hall, Orsi Giricz, Amit Verma, David J Prezant, Carl Ola Landgren
Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster. Blood cancer journal 12 (8) (2022)
Dickran Kazandjian, Andrew Kowalski, Carl Ola Landgren
T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscape. Leukemia & lymphoma (2022)
Malin Hultcrantz, Even Holth Rustad, Venkata Yellapantula, Allison Jacob, Theresia Akhlaghi, Neha Korde, Sham Mailankody, Alexander M Lesokhin, Hani Hassoun, Eric L Smith, Oscar B Lahoud, Heather J Landau, Gunjan L Shah, Michael Scordo, David J Chung, Sergio A Giralt, Elli Papaemmanuil, Carl Ola Landgren
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Leo Rasche, Carolina D Schinke, Francesco Maura, Michael A Bauer, Cody Ashby, Shayu Deshpande, Alexandra M Poos, Maurizio Zangari, Sharmilan Thanendrarajan, Faith E Davies, Brian A Walker, Bart Barlogie, Carl Ola Landgren, Gareth J Morgan, Frits van Rhee, Niels Weinhold
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states. Nature communications 13 (1) (2022)
Raleigh Ayoolu Fatoki, Kelly Koehn, Amar H Kelkar, Samer A Al Hadidi, Nikita Mehra, Hira S Mian, Carl Ola Landgren, Dickran Kazandjian, James Hoffman, Douglas W Sborov, Ghulam Rehman Mohyuddin
Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies. JCO global oncology 8 (2022)
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, Daniel A Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T Diamond, Ingrid Arijs, Brigitte Maes, Kimberly Vanhees, Malin L Hultcrantz, Elisabet E Manasanch, Dickran Kazandjian, Alexander Lesokhin, Ahmet Dogan, Yanming Zhang, Aneta Mikulasova, Brian A Walker, Gareth J Morgan, Peter J Campbell, Carl Ola Landgren, Jean-Luc Rummens, Niccolò Bolli, Francesco Maura
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities. Nature communications 12 (1) (2021)
Eileen M Boyle, Louis Williams, Patrick Blaney, Cody Ashby, Michael A Bauer, Brian A Walker, Hussein Ghamlouch, Jinyoung Choi, Emeline Perrial, Yubao Wang, Jessica Caro, James H Stoeckle, Arnaldo Arbini, David Kaminetzky, Marc Braunstein, Benedetto Bruno, Beatrice Razzo, Benjamin T Diamond, Kylee H Maclachlan, Francesco Maura, Carl Ola Landgren, Rachel Litke, Christopher D Fegan, Jonathan J Keats, Daniel Auclair, Faith E Davies, Gareth J Morgan
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length. Leukemia (2021)
Francesco Maura, Niels Weinhold, Benjamin T Diamond, Dickran Kazandjian, Leo Rasche, Gareth J Morgan, Carl Ola Landgren
The mutagenic impact of melphalan in multiple myeloma. Leukemia 35 (8) (2021)
Even H Rustad, Ferran Nadeu, Nicos Angelopoulos, Bachisio Ziccheddu, Niccolò Bolli, Xose S Puente, Elias Campo, Carl Ola Landgren, Francesco Maura
mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies. Communications biology 4 (1) (2021)
Kenneth C Anderson, Daniel Auclair, Stacey J Adam, Amit Agarwal, Melissa Anderson, Herve Avet-Loiseau, Mark Bustoros, Jessica R Chapman, Dana E Connors, Ajeeta B Dash, Alessandra Di Bacco, Ling Du, Thierry Facon, Juan A Flores-Montero, Francesca Gay, Irene M Ghobrial, Nicole J Gormley, Ira Gupta, Howard Higley, Jens Hillengass, Bindu Kanapuru, Dickran Kazandjian, Gary J Kelloff, Ilan R Kirsch, Brandon E Kremer, Carl Ola Landgren, Elizabeth D Lightbody, Oliver C Lomas, Sagar Lonial, Maria Victoria Mateos, Rocio Montes de Oca, Lata Mukundan, Nikhil C Munshi, Elizabeth K O'Donnell, Alberto Orfao, Bruno Paiva, Reshma Patel, Trevor J Pugh, Karthik Ramasamy, Jill Ray, Mikhail Roshal, Jeremy A Ross, Caroline C Sigman, Katie L Thoren, Suzanne Trudel, Gary A Ulaner, Nancy Valente, Brendan M Weiss, Elena Zamagni, Shaji K Kumar
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Saemundur Rognvaldsson, Thorvardur Jon Love, Sigrún Þorsteinsdóttir, Elín Ruth Reed, Jón Þórir Óskarsson, Íris Pétursdóttir, Guðrún Ásta Sigurðardóttir, Brynjar Viðarsson, Páll Torfi Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Ásdís Rósa Þórðardóttir, Elías Eyþórsson, Ásbjörn Jónsson, Andri S Björnsson, Gunnar Þór Gunnarsson, Runólfur Pálsson, Ólafur Skúli Indriðason, Gauti Kjartan Gíslason, Andri Ólafsson, Guðlaug Katrín Hákonardóttir, Manje Brinkhuis, Sara Lovísa Halldórsdóttir, Tinna Laufey Ásgeirsdóttir, Hlíf Steingrímsdóttir, Ragnar Danielsen, Inga Dröfn Wessman, Petros Kampanis, Malin Hulcrantz, Brian G M Durie, Stephen Harding, Carl Ola Landgren, Sigurður Yngvi Kristinsson
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood cancer journal 11 (5) (2021)
Bachisio Ziccheddu, Matteo Claudio Da Via, Marta Lionetti, Akihiro Maeda, Silvia Morlupi, Matteo Dugo, Katia Todoerti, Stefania Oliva, Mattia D'Agostino, Paolo Corradini, Carl Ola Landgren, Francesco Iorio, Loredana Pettine, Alessandra Pompa, Martina Manzoni, Luca Baldini, Antonino Neri, Francesco Maura, Niccolo' Bolli
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Eileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, Cody Ashby, Yan Wang, Michael A Bauer, Sarah K Johnson, Christopher Paul Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Facon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Carl Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina D Schinke, Faith E Davies, Gareth J Morgan, Brian A Walker
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma. Nature communications 12 (1) (2021)
Saemundur Rognvaldsson, Elias Eythorsson, Sigrún Þorsteinsdóttir, Brynjar Vidarsson, Pall Torfi Onundarson, Bjarni A Agnarsson, Margret Sigurdardottir, Ingunn Thorsteinsdóttir, Isleifur Olafsson, Hrafnhildur L Runolfsdottir, Dadi Helgason, Arna Rut Emilsdóttir, Arnar S Agustsson, Aron Hjalti Bjornsson, Gudrun Kristjansdottir, Asdis Rosa Thordardottir, Olafur Skuli Indridason, Olafur S Indridason, Gauti Kjartan Gíslason, Andri Olafsson, Hlif Steingrimsdottir, Petros Kampanis, Malin L Hultcrantz, Brian G M Durie, Stephen Harding, Carl Ola Landgren, Runolfur Palsson, Thorvarður Jon Love, Sigurður Yngvi Kristinsson
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study. Blood cancer journal 11 (12) (2021)
Kylee H Maclachlan, Even H Rustad, Andriy Derkach, Binbin Zheng-Lin, Venkata Yellapantula, Benjamin T Diamond, Malin L Hultcrantz, Bachisio Ziccheddu, Eileen M Boyle, Patrick Blaney, Niccolò Bolli, Yanming Zhang, Ahmet Dogan, Alexander M Lesokhin, Gareth J Morgan, Carl Ola Landgren, Francesco Maura
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma. Nature communications 12 (1) (2021)
Heather J Landau, Venkata Yellapantula, Benjamin T Diamond, Even Holth Rustad, Kylee H Maclachlan, Gunes Gundem, Juan Medina-Martinez, Juan Arango Ossa, Max Fine Levine, Yangyu Zhou, Rajya Kappagantula, Priscilla Baez, Marc A Attiyeh, Alvin Makohon-Moore, Lance Zhang, Eileen M Boyle, Cody Ashby, Patrick Blaney, Minal Patel, Yanming Zhang, Ahmet Dogan, David J Chung, Sergio Giralt, Oscar B Lahoud, Jonathan U Peled, Michael Scordo, Gunjan Shah, Hani Hassoun, Neha S Korde, Alexander M Lesokhin, Sydney Lu, Sham Mailankody, Urvi A Shah, Eric Smith, Malin L Hultcrantz, Gary A Ulaner, Frits van Rhee, Gareth J Morgan, Carl Ola Landgren, Elli Papaemmanuil, Christine A Iacobuzio-Donahue, Francesco Maura
Author Correction: Accelerated single cell seeding in relapsed multiple myeloma. Nature communications 12 (1) (2021)
Even Holth Rustad, Venkata Yellapantula, Daniel Leongamornlert, Niccolò Bolli, Guy Ledergor, Ferran Nadeu, Nicos Angelopoulos, Kevin J Dawson, Thomas J Mitchell, Robert J Osborne, Bachisio Ziccheddu, Cristiana Carniti, Vittorio Montefusco, Paolo Corradini, Kenneth C Anderson, Philippe Moreau, Elli Papaemmanuil, Ludmil B Alexandrov, Xose S Puente, Elias Campo, Reiner Siebert, Herve Avet-Loiseau, Carl Ola Landgren, Nikhil Munshi, Peter J Campbell, Francesco Maura
Timing the initiation of multiple myeloma. Nature communications 11 (1) (2020)
Hans C Lee, Noopur S Raje, Carl Ola Landgren, Vijay V Upreti, Jin Wang, Ariel A Avilion, Xuguang Hu, Erik Rasmussen, Gataree Ngarmchamnanrith, Hisaki Fujii, Andrew Spencer
Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma. Leukemia 35 (1) (2020)
Dickran Kazandjian, Clifton C Mo, Carl Ola Landgren, Paul Gerard Richardson
The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift? British journal of haematology 191 (5) (2020)
Malin L Hultcrantz, Even Holth Rustad, Venkata Yellapantula, Maria Arcila, Caleb Ho, Mustafa H Syed, Elli Papaemmanuil, Yanming Zhang, Francesco Maura, Carl Ola Landgren
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment. Blood cancer journal 10 (7) (2020)
Heather J Landau, Venkata Yellapantula, Benjamin T Diamond, Even Holth Rustad, Kylee H Maclachlan, Gunes Gundem, Juan Medina-Martinez, Juan Arango Ossa, Max Fine Levine, Yangyu Zhou, Rajya Kappagantula, Priscilla Baez, Marc A Attiyeh, Alvin Makohon-Moore, Lance Zhang, Eileen M Boyle, Cody Ashby, Patrick Blaney, Minal Patel, Yanming Zhang, Ahmet Dogan, David J Chung, Sergio Giralt, Oscar B Lahoud, Jonathan U Peled, Michael Scordo, Gunjan Shah, Hani Hassoun, Neha S Korde, Alexander M Lesokhin, Sydney Lu, Sham Mailankody, Urvi A Shah, Eric Smith, Malin L Hultcrantz, Gary A Ulaner, Frits van Rhee, Gareth J Morgan, Carl Ola Landgren, Elli Papaemmanuil, Christine A Iacobuzio-Donahue, Francesco Maura
Accelerated single cell seeding in relapsed multiple myeloma. Nature communications 11 (1) (2020)
Carl Ola Landgren, Ajai Chari, Yael C Cohen, Andrew Spencer, Peter Voorhees, Jane A Estell, Irwindeep Sandhu, Matthew W Jenner, Catherine Williams, Michele Cavo, Niels W C J van de Donk, Meral Beksac, Philippe Moreau, Hartmut Goldschmidt, Steven Kuppens, Rajesh Bandekar, Pamela L Clemens, Tobias Neff, Christoph Heuck, Ming Qi, Craig C Hofmeister
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS). Leukemia 34 (7) (2020)
Weixin Wang, Youn K Shim, Joel E Michalek, Emily Barber, Layla M Saleh, Byeong Yeob Choi, Chen-Pin Wang, Norma Ketchum, Rene Costello, Gerald E Marti, Robert F Vogt, Carl Ola Landgren, Katherine R Calvo
Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance. Journal of toxicology and environmental health. Part A 83 (7) (2020)
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, Assen S Kirov, Christopher C Riedl, Ryan Min, Eric Smith, Lukas Michael Carter, Serge K Lyashchenko, Jason S Lewis, Carl Ola Landgren
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging. Radiology 295 (3) (2020)
Matthew J Pianko, Sean M Devlin, Eric R Littmann, Aisara Chansakul, Donna Mastey, Meghan Salcedo, Emily Fontana, Lilan Ling, Elizabet Tavitian, John B Slingerland, Ann E Slingerland, Annelie Clurman, Antonio L C Gomes, Ying Taur, Eric G Pamer, Jonathan U Peled, Marcel R M van den Brink, Carl Ola Landgren, Alexander M Lesokhin
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood advances 3 (13) (2020)
Venkata Yellapantula, Malin L Hultcrantz, Even Holth Rustad, Ester Wasserman, Dory Londono, Robert Cimera, Amanda Ciardiello, Heather Landau, Theresia Akhlaghi, Sham Mailankody, Minal Patel, Juan Santiago Medina-Martinez, Juan Esteban Arango Ossa, Max Fine Levine, Niccolo Bolli, Francesco Maura, Ahmet Dogan, Elli Papaemmanuil, Yanming Zhang, Carl Ola Landgren
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood cancer journal 10 (1) (2020)
Ahmet Dogan, David Siegel, Nguyet Tran, Alan Fu, Jessica Fowler, Rajesh Belani, Carl Ola Landgren
B-cell maturation antigen expression across hematologic cancers: a systematic literature review. Blood cancer journal 10 (6) (2020)
Francesco Maura, Even H Rustad, Venkata Yellapantula, Marta Łuksza, David Hoyos, Kylee H Maclachlan, Benjamin T Diamond, Benjamin D Greenbaum, Gareth Morgan, Alexander Lesokhin, Elli Papaemmanuil, Carl Ola Landgren
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma. Leukemia 34 (5) (2019)
Venkata Yellapantula, Malin L Hultcrantz, Even Holth Rustad, Ester Wasserman, Dory Londono, Robert Cimera, Amanda Ciardiello, Heather Landau, Theresia Akhlaghi, Sham Mailankody, Minal Patel, Juan Santiago Medina-Martinez, Juan Esteban Arango Ossa, Max Fine Levine, Niccolo Bolli, Francesco Maura, Ahmet Dogan, Elli Papaemmanuil, Yanming Zhang, Carl Ola Landgren
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma. Blood cancer journal 9 (12) (2019)
Nikoletta Lendvai, Ioanna Tsakos, Sean M Devlin, Wendy L Schaffer, Hani Hassoun, Alexander M Lesokhin, Heather J Landau, Neha Korde, Sham Mailankody, Eric Smith, David J Chung, Guenther Koehne, Gunjan L Shah, Aeri Alexander, Minal Patel, Andrea Ballagi, Ida Grundberg, Sergio A Giralt, Carl Ola Landgren
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity. Leukemia & lymphoma 59 (8) (2018)
Carl Ola Landgren
Racial/ethnic disparities: need more work! Blood 130 (15) (2018)
Sham Mailankody, Dickran Kazandjian, Neha Korde, Mark Roschewski, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mary Kwok, Yong Zhang, Adriana Zingone, Laurence Lamy, Rene Costello, Candis Morrison, Malin Hultcrantz, Austin Christofferson, Megan Washington, Martin Boateng, Seth M Steinberg, Maryalice Stetler-Stevenson, William D Figg, Elli Papaemmanuil, Wyndham H Wilson, Jonathan J Keats, Carl Ola Landgren
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma. Blood advances 1 (22) (2017)
Matthew J Pianko, Samuel A Funt, David B Page, Deepika Cattry, Emma C Scott, Stephen M Ansell, Ivan M Borrello, Martin Gutierrez, Nikoletta Lendvai, Hani Hassoun, Carl Ola Landgren, Alexander M Lesokhin
Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma. Leukemia & lymphoma 59 (1) (2017)
Dalia Abdel-Raouf Salem, Neha Korde, David J Venzon, David J Liewehr, Irina Maric, Katherine R Calvo, Raul Braylan, Prashant R Tembhare, Constance M Yuan, Carl Ola Landgren, Maryalice Stetler-Stevenson
Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma. Leukemia & lymphoma 59 (1) (2017)
Talib Dosani, Sham Mailankody, Neha Korde, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Mary Kwok, Dickran Kazandjian, Rene Costello, Debra Burton, Yong Zhang, David Liewehr, Seth M Steinberg, Irina Maric, Carl Ola Landgren
Host-related immunodeficiency in the development of multiple myeloma. Leukemia & lymphoma 59 (5) (2017)
Arnab Ghosh, Sham Mailankody, Sergio A Giralt, Carl Ola Landgren, Eric L Smith, Renier J Brentjens
CAR T cell therapy for multiple myeloma: where are we now and where are we headed? Leukemia & lymphoma 59 (9) (2017)
Sundararajan Vincent Rajkumar, Carl Ola Landgren, María-Victoria Mateos
Smoldering multiple myeloma. Blood 125 (20) (2015)

Carl Ola Landgren.css-eqlu8i{font-size:small;padding-left:4px;} (Ola Landgren, C Ola Landgren)

Publication Activity (10 Years)

Top Topics

Top Venues

Carl Ola Landgren (Ola Landgren, C Ola Landgren)